Drug Report History #235624
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v14-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated (Changed) | Updated to: 2025-02-19 | Was: 2024-08-21 |
| Drug Identification Number | 02402076 | 02402076 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Company Name | AURO PHARMA INC | AURO PHARMA INC |
| Ingredients | TAZOBACTAM PIPERACILLIN | TAZOBACTAM PIPERACILLIN |
| Strength(s) | 0.375G 3G | 0.375G 3G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | Vial | Vial |
| Additional packaging sizes | ||
| ATC code | J01CR | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage (Changed) | Updated to: Other (Please describe in comments) | Was: Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2024-08-21 | 2024-08-21 |
| Estimated end date (Changed) | Updated to: Unknown | Was: 2024-09-15 |
| Actual end date (Changed) | Updated to: 2025-02-18 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Please be informed PIPERACILLIN AND TAZOBACTAM FOR INJECTION is now available under Eugia label DIN: 02528703 | Was: |
| Health Canada comments |